| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 50 |
| 1 | METHOTREXATE | 38 |
| 2 | ISONIAZID | 34 |
| 3 | INFLIXIMAB | 26 |
| 4 | LEFLUNOMIDE | 22 |
| 5 | CELECOXIB | 21 |
| 6 | SULFASALAZINE | 21 |
| 7 | TOCILIZUMAB | 16 |
| 8 | ADALIMUMAB | 14 |
| 9 | ETANERCEPT | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISONIAZID | 34 | 0.0021 |
| 1 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 6 | 0.0017 |
| 2 | RALTEGRAVIR | 5 | 0.0010 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 6 | 0.0009 |
| 4 | RIFAMPIN | 14 | 0.0009 |
| 5 | AVACOPAN | 6 | 0.0009 |
| 6 | DARUNAVIR 600 MG | 5 | 0.0008 |
| 7 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 8 | HYALURONATE SODIUM | 1 | 0.0007 |
| 9 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 45 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 2 | Antimycobacterial [EPC] | 34 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 4 | Corticosteroid [EPC] | 27 |
| 5 | Aminosalicylate [EPC] | 22 |
| 6 | Antirheumatic Agent [EPC] | 22 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 16 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 9 | Rifamycin Antibacterial [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimycobacterial [EPC] | 34 | 0.0014 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 6 | 0.0009 |
| 2 | Rifamycin Antibacterial [EPC] | 14 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 4 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 6 | Aminosalicylate [EPC] | 22 | 0.0002 |
| 7 | Antirheumatic Agent [EPC] | 22 | 0.0002 |
| 8 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |